Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The losartan intervention for endpoint reduction in hypertension (LIFE) trial. - Devereux,R.B.; Dahlof,B.; Gerdts,E. (Circulation, 2004)